Today, Baxter, a prominent player in the global medtech arena, disclosed its financial outcomes for the fourth quarter and the entirety of 2023, concluding on December 31st. Additionally, the company outlined its financial projections for both the full-year and the…
Today’s announcement unveils Otsuka Foods’ plans to introduce five revamped Bon Curry NEO products, each boasting a richer flavor profile, all under the renowned Bon Curry brand. Set for release nationwide on Monday, March 4, 2024, these relaunched items mark…
Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) has announced today the approval of crovalimab (known as 派圣凯® in China), a humanized complement inhibitor C5 monoclonal antibody developed by Chugai, by the National Medical Products Administration (NMPA) of the People’s Republic of…
Merck, a renowned science and technology enterprise, has announced the appointment of Michael Kleinemeier (66) as the Chair of its Supervisory Board. Kleinemeier, who previously served as a member of the Executive Board at SAP SE in the capacity of…
Eli Lilly and Company (NYSE:LLY) has announced that Philip Johnson, the group vice president and treasurer, will be retiring from the company after more than 28 years of service. His retirement is scheduled for the end of February, as he…
New data indicate that treatment with Nexviazyme® (avalglucosidase alfa) has significantly improved ptosis, or drooping eyelid, in pediatric patients with infantile-onset Pompe disease (IOPD) over nearly three years. These findings, presented at the 20th annual WORLDSymposiumTM, include positive safety results…
The American Cancer Society (ACS) and Pfizer Inc. (NYSE: PFE) have jointly unveiled the “Change the Odds: Uniting to Improve Cancer Outcomes™” initiative, a three-year program aimed at addressing disparities in cancer care. With $15 million in funding from Pfizer,…
Novo Nordisk has announced its agreement to acquire three fill-finish sites from Novo Holdings A/S as part of the transaction where Novo Holdings will acquire Catalent, Inc., a global contract development and manufacturing organization headquartered in Somerset, New Jersey (US).…
Eli Lilly and Company (NYSE: LLY) disclosed its financial outcomes for the final quarter of 2023, marking a year of notable accomplishments characterized by substantial revenue growth. David A. Ricks, Lilly’s chair and CEO, emphasized the company’s impactful contributions in…
FDA Grants Fast Track Designation to BioNTech and DualityBio for Next-Generation Antibody-Drug Conjugate Candidate BNT325/DB-1305 BioNTech SE (Nasdaq: BNTX, “BioNTech”) and Duality Biologics (Suzhou) Co., Ltd. (“DualityBio”) today announced that the U.S. Food and Drug Administration (“FDA”) granted Fast Track designation for BNT325/DB-1305…
Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; referred to as “Shionogi”) has revealed that Pixie Dust Technologies, Inc. (Head Office: Tokyo, Japan; Representative Directors: Yoichi Ochiai and Taiichiro Murakami; referred to as “PxDT”)…
Bio-Techne Corporation (NASDAQ: TECH) has released its financial results for the second quarter ending December 31, 2023. Key Highlights for the Second Quarter of Fiscal Year 2024: Bio-Techne’s financial statements are prepared in accordance with Generally Accepted Accounting Principles (GAAP).…
